The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,375.00
Bid: 11,200.00
Ask: 11,550.00
Change: -100.00 (-0.88%)
Spread: 350.00 (3.125%)
Open: 11,275.00
High: 11,200.00
Low: 11,200.00
Prev. Close: 11,300.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Interim Results

20 Jul 2017 07:00

RNS Number : 5604L
Judges Scientific PLC
20 July 2017
 

Judges Scientific PLC

 

Press Release

20 July 2017

 

Judges Scientific Plc

("Judges Scientific" or "the Group")

Trading Update and Notice of Interim Results

 

The Directors of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, update shareholders and the market regarding the Group's trading performance during the first half of the current financial year.

The Group's results for the six-month period to 30 June 2017 will include a full contribution from CoolLED Limited and Dia-Stron Limited, which were acquired in the first quarter of 2016, and a first time contribution from EWB Solutions Limited which was acquired in November 2016. "Organic" in this statement excludes the performance of these businesses.

Order intake

Order intake in the first quarter was very strong, reversing the trend seen since 2014. This was followed by a good second quarter. Consequently, for the first half as a whole, the Group experienced 28.1% Organic growth in order intake from the same period last year. The Organic order book finished the first half at 16.5 weeks of sales against 11.2 weeks at 30 June 2016 and 14.9 weeks at the beginning of the period. Most Group businesses participated in this progress, including the two companies that had underperformed in 2016 due to low demand. The recent acquisitions also enjoyed satisfactory demand and booked orders in line with their annual budgets. As at 30 June 2017, the Group's total order book, which includes recently acquired companies, stood at 15.4 weeks.

First Half Performance

The healthy order book available at the end of 2016 and the continuing strength in order inflow since then, have enabled virtually all Organic businesses to increase their sales revenue in the first half compared to the same period in 2016. As a consequence, the Group experienced double digit percentage Organic sales growth on a like for like basis from the prior year. The production issues affecting one of the companies in our vacuum segment have necessitated an extensive change in its management team early this year; the company managed to deliver marginal sales growth in the first half but much remains to be done.

The Board expects the interim results to show solid progress in revenues, EBIT and earnings per share.

Full Year Outlook

The sustained strength in order intake in the last twelve months and the continued weakness of Sterling provide the Board with confidence that the Group can deliver a full year performance in line with market expectations. The recently announced acquisition of Oxford Cryosystems reinforces that confidence and reaffirms the strategic role of acquisitions in the Group's pursuit of shareholder value.

Notice of Results

The Company expects to announce its interim results for the six months to 30 June 2017 on 20 September 2017.

 

- Ends -

 

For further information please contact:

 

Judges Scientific

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

 

Media enquiries:

Abchurch (Financial Public Relations)

Julian Bosdet

Dylan Mark

Alejandra Campuzano

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.  The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies have been awarded five Queen's Awards for innovation and export. 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFRDFIALID
Date   Source Headline
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker
31st Mar 20238:54 amRNSGrant of Options
22nd Mar 20237:00 amRNSFinal Results
8th Mar 20232:39 pmRNSTotal Voting Rights
8th Mar 20237:00 amRNSDirector/PDMR Shareholding
13th Feb 20238:48 amRNSDirector/PDMR Shareholding
2nd Feb 20239:17 amRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSExecutive Director and Board Appointment
1st Feb 20237:00 amRNSTotal Voting Rights
23rd Jan 202310:27 amRNSGrant of Options
19th Jan 20237:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20231:03 pmRNSTotal Voting Rights
21st Dec 202210:51 amRNSBlock listing Interim Review
20th Dec 202211:53 amRNSDirector/PDMR Shareholding
12th Dec 20228:52 amRNSHolding(s) in Company
6th Dec 20222:34 pmRNSDirector/PDMR Shareholding
1st Dec 202210:01 amRNSTotal Voting Rights
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20228:54 amRNSDirector/PDMR Shareholding
7th Nov 20225:14 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 20223:55 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:01 amRNSTotal Voting Rights
23rd Sep 20223:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
6th Sep 20222:51 pmRNSDirector/PDMR Shareholding
2nd Sep 20223:16 pmRNSTotal Voting Rights
9th Aug 20229:20 amRNSDirector/PDMR Shareholding
1st Aug 202211:07 amRNSTotal Voting Rights
27th Jul 20224:08 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20228:12 amRNSDirector/PDMR Shareholding
1st Jul 20225:34 pmRNSTotal Voting Rights
29th Jun 202211:13 amRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSAcquisition of minority shareholding in Bordeaux
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
10th Jun 202211:43 amRNSBlocklisting Return
9th Jun 202212:11 pmRNSDirector/PDMR Shareholding
9th Jun 20227:36 amRNSIssue of Shares – Replacement
8th Jun 20223:52 pmRNSIssue of Ordinary Shares
6th Jun 20223:00 pmRNSPurchase of Ordinary Shares
1st Jun 202212:48 pmRNSTotal Voting Rights
27th May 20221:08 pmRNSAppointment of auditor
24th May 20222:12 pmRNSResult of AGM
23rd May 202211:05 amRNSSecond Price Monitoring Extn
23rd May 202211:00 amRNSPrice Monitoring Extension
23rd May 20227:00 amRNSAcquisition of Geotek and new banking facilities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.